GEN-MKT-18-7897-A
Aug 27, 2019 | Blogs, Food / Beverage | 0 comments
Now that cannabis is legalized in a majority of the United States and Canada, new regulations to help protect consumers lead us to an important question: What are they getting? Here, we’ll help provide the answer.
Image source: Shayanne Gal/Business Insider
Some of the main goals behind cannabis regulation are to ensure that consumers know what’s in their cannabis and that the products aren’t contaminated with things like harmful pesticides. One evaluation of the most readily available CBD products in the US (from online retailers) showed only 31% were accurately labeled for CBD concentration. The study highlighted the need for manufacturing and testing standards and general oversight of cannabis products.
State testing regulations for pesticides in cannabis products are inconsistent. For example, California implemented mandatory testing shortly after legalization in early 2018, but Washington has prohibited the use of certain pesticides and doesn’t require any testing. There are all sorts of reasons why cannabis can become contaminated with pesticides, but the only way to know for sure is to test. In California, 3,373 batches of cannabis products failed safety testing between July 1 and November 30, 2018. Of those failures, 700 rejections were because of pesticides.
While the enforcement of mandatory pesticide testing remains a challenge for some, there are also analytical challenges that cannabis testing labs need to overcome.
Cannabis Analysis That’s Up to the ChallengeWhen it comes to making your lab operations more efficient and productive, you need a high-performance instrument that’s tough enough to handle routine cannabis testing and to meet the needs of ongoing regulatory changes. You need an LC-MS/MS solution that can stand up to these common testing challenges:
SCIEX offers world-class solutions designed to simplify your workflows and get you operational as quickly as possible. Explore the incredibly sensitive SCIEX Triple Quad™ 6500+ or QTRAP® 6500+ system featuring advanced SCIEX technology, combined with our vMethod™ and our expert application support and training.
Download the Top 5 Pesticides Challenges in Cannabis to find out how SCIEX can make your laboratory operations easier and more productive.
The Echo® MS+ system is a novel platform for Acoustic Ejection Mass Spectrometry (AEMS) and combines the speed of acoustic sampling with the selectivity of mass spectrometry. This platform has been designed for high throughput analysis of small and large molecules. The technology combines Acoustic Droplet Ejection (ADE), an Open Port Interface (OPI) and could be coupled with the SCIEX Triple Quad 6500+ system or the ZenoTOF 7600 system.
The Echo® MS+ system comprises of an open-port interface (OPI) and acoustic droplet ejection (ADE) module which could be coupled with a mass spectrometer. The mass spectrometer could either be a SCIEX Triple Quad 6500+ system or the ZenoTOF 7600 system. This non-liquid chromatography based; high-throughput screening platform enables rapid analysis of compounds at speeds of up to 1 sample/second.
The ability to consistently achieve reproducible results on many complex samples across multiple days is critical to a routine clinical laboratory. Laboratories relying on analytical instrumentation require stability and robustness to perform a variety of screening and confirmatory assays with confidence. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has become the preferred analytical method in the clinical laboratory to reliably perform clinical testing as it provides best-in-class performance and reliability for the most challenging assays. LC-MS/MS offers the required levels of sensitivity and specificity for the detection and quantitation of molecules from complex biological samples, helping laboratories deliver highly accurate data for a variety of clinically relevant analytes across a wide range of assays.
Posted by
You must be logged in to post a comment.
Share this post with your network